Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related SPPI
Spectrum Pharma Reports Publication of Beleodaq Data Selected as Rapid Communication in JCO
Time To Buy Casi Pharma, HC Wainwright
Related GALT
Morning Market Gainers
Wednesday Morning Movers
Seeking Alpha's Biotech Weekly: Celgene-Juno, Gilead's HIV NDA, Happy 4th! (Seeking Alpha)

Analysts at HC Wainwright initiated coverage on shares of Spectrum Pharmaceuticals (NASDAQ: SPPI) with a “buy” rating. The target price for Spectrum Pharmaceuticals is set to $15. Spectrum's shares closed at $8.49 on Friday.

Ascendiant Capital initiated coverage on shares of Galectin Therapeutics (NASDAQ: GALT) with a “buy” rating. The target price for Galectin Therapeutics is set to $13. Galectin Therapeutics' shares closed at $11.00 on Friday.

Analysts at Morgan Stanley initiated coverage on shares ITC Holdings (NYSE: ITC) with an “overweight” rating. The target price for ITC Holdings is set to $105. ITC's stock closed at $93.13 on Friday.

Atlantic Equities initiated coverage on shares of Facebook (NASDAQ: FB) with an “overweight” rating. The target price for Facebook is set to $63. Facebook's shares closed at $51.04 on Friday.

Latest Ratings for SPPI

DateFirmActionFromTo
Apr 2015FBR CapitalInitiates Coverage onOutperform
Mar 2015JefferiesMaintainsHold
Feb 2015Roth CapitalDowngradesBuy

View More Analyst Ratings for SPPI
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (FB + GALT)

Around the Web, We're Loving...

Get Benzinga's Newsletters